Advance Biopharma Tech Transfer Using Process Modeling and Simulation

While biotherapeutics is one of the fastest growing sectors in life sciences today, the tech transfer process still takes many years. Regulatory approval can be time consuming—from conducting clinical trials to achieving a validated process design.

In this on-demand webinar, Dr. Monica Lomeli, Pharma Principal Solution Consultant at AspenTech, and Dr. Mark-John Bruwer, Senior Director of Strategic Product Marketing at AspenTech, discuss how regulators, such as the FDA, are implementing process modeling and simulation to accelerate knowledge creation for faster, more efficient system design. Learn how innovations including mechanistic and hybrid modeling enable you to:

  • Rapidly design for optimal yield, shorter cycle time and robust operation
  • Gain new insights into the optimization of downstream purification processes
  • Leverage the same science- and engineering-based approach used by regulators

Watch to learn how you can expand your toolset to advance tech transfer and accelerate regulatory submissions.

Advance Biopharma Tech Transfer Using Process Modeling and Simulation

Why we collect this data

AspenTechは、当社の事業、可能な限り最善の製品やカスタマーサービスのご提供、そして全体的なユーザエクスペリエンスに関わるさまざまな理由でお客様の個人データを収集および処理する場合があります。当社はお客様の個人データを使用して適宜、アンケートや調査の管理、契約サービスの正確な提供、イベントへの登録、お客様の好みの理解、および不正または不正な活動の検出と防止を行う場合があります。個人データの収集と処理の詳細については、こちらからAspenTechのプライバシーおよびセキュリティポリシーを参照してください。

Advance Biopharma Tech Transfer Using Process Modeling and Simulation

Hello . If this is not you

Thank you for viewing this on-demand webinar

If you weren't redirected, click here